Gregory S. Wessels Aprea Therapeutics, Inc. (APRE) insider trading activity

APRE Quotes by TradingView

Gregory S. Wessels is SVP, Chief Commercial Officer of Aprea Therapeutics, Inc.. Currently has a direct ownership of 16,000 shares of APRE, which is worth approximately $46,080. The most recent transaction as insider was on Feb 25, 2021, when has been sold 16,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16K
0% 3M change
0% 12M change
Total Value Held $46,080

Gregory S. Wessels Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 25 2021
BUY
Grant, award, or other acquisition
-
16,000 Added 50.0%
16,000 Common Stock
GSW

Gregory S. Wessels

SVP, Chief Commercial Officer
Boston, MA

Track Institutional and Insider Activities on APRE

Follow Aprea Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APRE shares.

Notify only if

Insider Trading

Get notified when an Aprea Therapeutics, Inc. insider buys or sells APRE shares.

Notify only if

News

Receive news related to Aprea Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on APRE